• Insights
    • Blog
    • Perspectives
    • Webinars
  • Offerings
    • Strategic Innovation
    • Digital innovation
    • Product innovation
    • High-tech innovation
    • On-site consulting
  • Markets
    • Space & security
    • FMCG
    • Life sciences
    • Industry
  • Capabilities
    • AILab
    • DesignLab
    • DigitalLab
    • EmbeddedLab
    • FabLab
    • InnoLab
    • MechLab
    • OpenLab
    • OpticsLab
    • PhysicsLab
  • Technologies
    • Technology portfolio
    • IoT & sensors
    • AI & data science
    • Robotics & autonomy
    • Cooling, heating & fluidics
  • About
    • News
    • Our story
  • Careers
  • Contact
Verhaert Masters in InnovationVerhaert Masters in Innovation
Verhaert Masters in InnovationVerhaert Masters in Innovation
  • Insights
        • Blog
        • Perspectives
        • Webinars
        • FEATURED
          Report 'AI in R&D'
  • Offerings
        • Strategic
          innovation
        • Digital
          innovation
        • Product
          innovation
        • High-tech
          innovation
        • On-site
          consulting
        • FEATURED
          Innovation Academy
  • Markets
        • Space & defense
        • FMCG
        • Life sciences
        • Industry
  • Capabilities
        • AILab
        • DesignLab
        • DigitalLab
        • EmbeddedLab
        • FabLab
        • InnoLab
        • MechLab
        • OpenLab
        • OpticsLab
        • PhysicsLab
  • Technologies
        • IoT & sensors
        • AI & data science
        • Robotics & autonomy
        • Cooling, heating & fluidics
        • Optics
  • About
        • News
        • Our story
  • Careers
  • Contact

Rebuilding MedTech innovation companies

1 February 2021 Posted by Frederik Wouters Life sciences

A person’s health is priceless, how can medical device companies turn rapidly changing technologies and user needs into new values.

Smart medical blogpost banner

Pouring more dollars into research and development (R&D) alone, is often not effective. Medical device companies should instead evaluate their traditional approach to innovate and search new strategies. That way they can look for new values and accommodate the challenges they are facing, such as:

  • Increasing regulatory complexities in global markets that are driving up costs and the risk of (expensive) compliance failure
  • Growing pressure on margins because of fierce competition
  • Rapidly emerging technologies that hard to keep up with
  • Smaller medical device manufacturers that traditionally drive innovation, but are now being joined in an increasingly crowded field

We believe that medical device companies need to embrace a MyInnovationFactory solution. This approach embeds more open innovation models, secures access to latest technology, pursues a data and service based business models. In addition it searches for more agile and multi-disciplinary (cross silo’s) R&D and innovation approaches and installs an “Innovation Garage” or Fablab.

Blueprint MyInnovationFactory

With profit margins being squeezed, improving efficiency in the R&D process is seen as the second biggest challenge. Knowing that the majority of MedTech devices companies are led by engineering or innovation, it even puts an even bigger burden on the organizational challenges to do more with less.

Forbes survey - Top 3 strategic priorities
Source: Forbes survey on the future of innovation for the medical device industry

Conclusion

Consumer technology companies (e.g., Google, Apple, Amazon, Microsoft, and others) are becoming increasingly equipped to innovate through Class I devices (low risk to patients). This pushes the barrier for MedTech companies to innovate. In this situation, rather than focusing on incrementally improving their hardware products, we advise the MedTech companies to focus on using transformative technologies. Moreover, we recommend shifting from incremental to breakthrough innovation and implementing a much more agile method to innovate while embedding open innovation in their core.

Professionalizing the innovation organization for adjacent and disruptive innovations can be achieved with a double focus. On the one hand, companies can embed an agile culture of innovation. On the other hand they can start learning progressively from failures and setbacks through a KPI-based portfolio. This will allow them to make insightful pivots when either technology drawback or negative market feedback is captured. Professionalizing innovation will be a catalyst for MedTech companies to drive value capturing for adjacent or disruptive innovation when moving away from traditional pricing models.

The traditional superior devices type of innovation will now be changed by solution innovation (devices, data & services) aiming for personalized, better patient treatment and outcome. Using an agile approach allows you to set up operations to develop requirements iteratively, and learn continuously from every sprint on market, busines, user and technological tracks. It also allows companies to make corrections to develop products based on changing company goals and competitive insights. Complacency and the old speed is unlikely to be sufficient in this race to leverage data in the future of health.

Any questions on this post? Submit them below and we’ll get back to you soon!

Tags: Digital transformationInnovation methodologyMedical innovation

You also might be interested in

Featured image - Webinar - Pretotyping

Pretotyping

Jun 5, 2020

Pretotyping is an innovation practice to market-test new ideas quickly & inexpensively, which you should've started applying it yesterday!

The missing link in innovation: Why R&D needs project management

The missing link in innovation: Why R&D needs project management

Feb 18, 2025

Learn how on-site project managers bridge R&D and marketing to drive innovation and bring products to market successfully.

Featured image - Medical blogpost 2

Focusing patient treatment on prevention & personalization

Feb 10, 2021

MedTech companies can transform patient treatment by focusing on prevention and personalization instead of illnesses.

Any questions? Curious how this can boost your business? Get in touch with Wouter!
Latest life sciences blogposts
  • 07/11/2024
    Bold trends in drug delivery: the path to value-based healthcare
  • 28/03/2024
    Closing the loop: sustainability in drug delivery ecosystems
  • 18/04/2023
    From science fiction to reality: AI & robotics in healthcare
  • 10/03/2023
    6 ways digital health is transforming medical devices
  • 14/02/2023
    Innovation in the air: how to build strong medical partnerships
Verhaert group

Verhaert Masters in Innovation is a pioneering innovation group helping companies and entrepreneurs to innovate, creating new products, businesses and services.

Verhaert icon LinkedIn Verhaert icon YouTube Verhaert icon Instagram Verhaert icon phone Verhaert icon mail

Offerings
Markets
Capabilities
Technologies
Perspectives
Blogs
Webinars
About
News
Careers
Contact

© 1969-2025 • Verhaert New Products & Services NV • BE 0439.039.420 • Privacy policy • Terms of use